Alkem’s Aim Adjusted: HSBC Trims Target Amid Pharma Headwinds

Unknown Apr 02, 2026 1,000 Views

Alkem Laboratories (ALKE.NS) saw its price target trimmed by global brokerage HSBC, with analysts revising their 12-month target down to ₹5,000 from the previous ₹5,160. The adjustment comes amid a broader wave of cautious sentiment toward Indian equities, as sector headwinds and softer earnings...